Latest Morphotek Inc. Stories
Clinical Study (003-011) to Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination with Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD)
SAN DIEGO, June 25, 2014 /PRNewswire/ -- Concortis Biosystems, Inc.
- A serpent whose bite was fabled to produce intense thirst.